Change language
Besuchen Sie uns auf den sozialen Netzwerken
Homepage  →  Neuigkeiten

EVENSWISS IN LATVIA - SKINBLOOM.EU

We're thrilled to unveil the latest addition for our vibrant community in Latvia! Evenswiss is delighted to introduce our esteemed distributor in Latvia, the fabulous Skinbloom.eu, led by the incredible Elina Zegnere-Poca—a professional beauty specialist with an eye for excellence.

Elina, a seasoned beauty specialist, selects only the best products for her customers. Her commitment to quality aligns seamlessly with Evenswiss's dedication to radiant and healthy skin.

Follow @skinbloom.eu and @kosmetike_elina_poca on social media for the latest updates, skincare rituals, and a daily dose of beauty inspiration.

We are really happy and satisfied to see EVENSWISS growing in Baltic countries. Let's embark on this radiant journey together!

Für weitere News klicken Sie hier

News und Events

27 März 2024

EVENSWISS at Cosmoprof Bologna 2024 Edition

On behalf of the entire Evenswiss team, we extend our warmest thanks to each and every one of you who honored the stand with your presence at Cosmoprof Bologna.

13 Februar 2024

Unlocking the Secrets of Skin Rejuvenation: A Recap of the EVENSWISS Seminars in Latvia and Lithuania with our official exclusive distributor Klinika AMELA

Recently, skincare professionals in Latvia and Lithuania had the exclusive opportunity to dive deeper into the world of skincare rejuvenation at the EVENSWISS x Klinika AMELA Seminars.

26 Dezember 2023

Celebrating a Year of Unforgettable Milestones with EVENSWISS - Our year in a nutshell

As we reflect on the incredible journey of the past year, we are deeply grateful for the milestones that have highlighted EVENSWISS's path.

26 November 2023

Successful Cosmoprof Asia Hong Kong 2023

We, EVENSWISS, had a successful week in Hong Kong in many ways. Constantly growing interest and demand in the Asian market is a true thing and one of the biggest key points for us. Needless to say, thanks to our unique products with Dermatopoietin, again gathered a huge amount of interest.